Sandoz Group AG (OTCMKTS:SDZNY - Get Free Report) shares shot up 1% on Thursday . The company traded as high as $42.49 and last traded at $41.71. 19,907 shares changed hands during trading, a decline of 79% from the average session volume of 92,822 shares. The stock had previously closed at $41.31.
Wall Street Analyst Weigh In
A number of brokerages have commented on SDZNY. Royal Bank of Canada downgraded shares of Sandoz Group from a "moderate buy" rating to a "hold" rating in a research note on Monday, September 16th. BNP Paribas cut Sandoz Group from a "strong-buy" rating to a "hold" rating in a research note on Monday, December 2nd.
Read Our Latest Stock Analysis on Sandoz Group
Sandoz Group Stock Down 1.3 %
The stock's 50 day moving average is $44.01 and its two-hundred day moving average is $41.72.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Featured Articles
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
